Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline

References

1. Babinchak T., Ellis-Grosse E., Dartois N., Rose G. M., Loh E. the Tigecycline 301 and 306 Study Groups; 2005; The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. . Clin Infect Dis 41 (Suppl. 5):S354–S367 [CrossRef]
   [Google Scholar]
2. Chatzinikolaou I., Abi-Said D., Bodey G. P., Rolston K. V. I., Tarrand J. J., Samonis G. 2000; Recent experience with Pseudomonas aeruginosa bacteremia in a patient with cancer. Arch Intern Med 160:501–509 [CrossRef]
   [Google Scholar]
3. Doan T. L., Fung H. B., Mehta D., Riska P. F. 2006; Tigecycline: a glycylcycline antimicrobial agent. Clin Ther 28:1079–1106 [CrossRef]
   [Google Scholar]
4. Ellis-Grosse E. J., Babinchak T., Dartois N., Rose G. M., Loh E. theTigecycline 300 and 305 cSSSI Study Groups; 2005; The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis 41 (Suppl. 5):S341–S353 [CrossRef]
   [Google Scholar]
5. Falagas M. E., Kasiakou S. K. 2006; Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10:R27 [CrossRef]
   [Google Scholar]
6. Jones M. E., Karlowsky J. A., Draghi D. C., Thornsberry C., Sahm D. F., Nathwani D. 2004; Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy. Int J Antimicrob Agents 23:240–246 [CrossRef]
   [Google Scholar]
7. Nelson C. L., McLaren S. G., Skinner R. A., Smeltzer M. S., Thomas J. R., Olsen K. M. 2002; The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res 20:643–647 [CrossRef]
   [Google Scholar]
8. Parody R., Martino R., Rovira M., Vazquez L., Vazquez M. J., de la Cámara R., Blazquez C., Fernández-Avilés F., Carreras E. other authors 2006; Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Bone Marrow Transplant 12:734–748 [CrossRef]
   [Google Scholar]
9. Rahal J. J. 2006; Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 43:S95–S99 [CrossRef]
   [Google Scholar]
10. Sader H. S., Jones R. N., Dowzicky M. J., Fritsche T. R. 2005a; Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn Microbiol Infect Dis 52:203–208 [CrossRef]
    [Google Scholar]
11. Sader H. S., Jones R. N., Stilwell M. G., Dowzicky M. J., Fritsche T. R. 2005b; Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents. Diagn Microbiol Infect Dis 52:181–186 [CrossRef]
    [Google Scholar]
12. Tice A. D., Hoaglund P. A., Shoultz D. A. 2003; Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 51:1261–1268 [CrossRef]
    [Google Scholar]
13. Timurkaynak F., Can F., Azap O. K., Demirbilek M., Arslan H., Karaman S. O. 2006; In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant stains of Pseudomonas aeruginosa and Acinetobacter baumanii isolated from intensive care units. Int J Antimicrob Agents 27:224–228 [CrossRef]
    [Google Scholar]
14. Townsend M. L., Pound M. W., Drew R. H. 2006; Tigecycline: a new glycylcycline antimicrobial. Int J Clin Pract 60:1662–1672 [CrossRef]
    [Google Scholar]
15. Williamson E. C., Millar M. R., Steward C. G., Cornish J., Foot A., Oakhill A., Pamphilon D., Reeves B., Caul E. O. other authors 1999; Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 104:560–568 [CrossRef]
    [Google Scholar]
16. Yin L. Y., Lazzarini L., Li F., Stevens C. M., Calhoun J. H. 2005; Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother 55:995–1002 [CrossRef]
    [Google Scholar]